Table of Contents
- Collaborate2Cure:The Role of Complex Gut Microbiota in the Susceptibility to Colorectal Cancer, James M. Amos-Landgraf, PhD
- Collaborate2Cure: Tolerance Induction for Organ Transplants by Myeloid Progenitor Cells, Jos Domen, PhD
- Collaborate2Cure: Translating Research into Clinical Practice in Hepatocellular Cancer, Kevin Staveley-O’Carroll, MD, PhD
- Collaborate2Cure:Tumor In a Dish: Novel Approach for Personalized Medicine, Shrikant Anant, PhD
- Collaborate2Cure:Quest for Developing Novel Immunological Assays for Cancer Immunotherapy, Francisco Martinez Becerra, PhD
- Collaborate2Cure: Isolation and Molecular Profiling of Circulating Tumor Cells with Divergent Phenotypes, Maggie Witek, PhD
- Collaborate2Cure: Immune Monitoring Toolkit for Canine Immunotherapy Trials, Jeffrey N. Bryan
- Collaborate2Cure: (2) Immune Monitoring Toolkit for Canine Immunotherapy Trials, Hans Rindt, PhD Sandra Bechtel, DVM, DACVIM
- Collaborate2Cure: Immunotherapy of Osteosarcoma, Laura Simon Treml, VMD, PhD
- Collaborate2Cure:Engineering Regulatory T Cells for the Treatment of Graft-Versus-Host Disease, Tom Yankee, PharmD, PhD
- Collaborate2Cure: Howling at the Cancer Moonshot, Carolyn Henry DVM, MS, DACVIM
- Collaborate2Cure: Treating Cancer with Ex Vivo-Activated Cancer Neoantigen-Specific Effector T Cells, Tammie Wahaus
- Collaborate2Cure: Kansas City One Health Day, Zika Virus, Stephen Higgs, PhD
- Collaborate2Cure: inCVAX: An in situ Autologous Cancer Vaccine, Joseph Raker, PhD
- Collaborate2Cure: Practical Considerations for Translation of CAR-T Cell Therapies to the Market, Sara Mary Hall
- Collaborate2Cure: Antigen-targeted Therapy for Head and Neck Cancer, Sufi Thomas, PhD
- Collaborate2Cure:Biomaterials for Cell Delivery in Animal Models, Gabriel Converse, PhD
- Collaborate2Cure: Hyperthermia: More Than an Adjuvant to Cancer Therapies, Stefan Bossmann, PhD
- Collaborate2Cure: Novel Approaches to the Design of Chimeric Antigen Receptors, Thomas Yankee, PhD
- Collaborate2Cure: Incorporation of NKG2D Signaling into Cancer Immunotherapy, Mary Markiewicz, PhD
- Collaborate2Cure: Advancing Immunotherapy in the Kansas City Region, Doug Myers, MD